Blog Report

Thursday, March 27, 2008

Restrictions in Essex County, England

In order to curb inhalant abuse, the Essex County Council Trading Standards in England are conducting undercover test sales for various inhalants. They use a 14-year-old girl who attempts to buy a butane refill. Five stores out of fifty made the sale. Here are the results:
On each occasion the volunteer, who was supervised throughout the process, attempted to purchase butane lighter refills. Statistics show that these account for the majority of deaths among people using them for intoxication purposes, due to volatile substance abuse (VSA).

A number of shops visited also indicated that they would have made the sale, but were out of stock or unable to locate their supply. Trading Standards officers re-visited these retailers to advise them on age restricted sales.

The stores visited included both smaller independent stores and major retail chains. Trading Standards officers said they were concerned that some retailers still believe that the legal age for purchasing solvents is 16, rather than 18.

Statistics compiled by St George's University of London show that VSA is responsible for more deaths amongst young people aged 10-16 than “conventional” illegal drugs.

Roger Walters, county council executive member for Trading Standards said:
“Solvent abuse is a serious problem, which is why these products should not be made available to young people under the age of 18. There is simply no excuse for stores to flout the law on this.

We are planning to conduct more test sales for solvents, and any retailers who continue to ignore our warnings can expect to be punished severely.”

Do you think that these restrictions will be effective? If so, which inhalants (solvents) should be limited to adults? Will it curb abuse from products already in the home? What about abuse in those older than 18?

Also, with over 1,400 abusable inhalants, it would not be feasible to ban each one from underage purchase. If those most popularly used were restricted, would a new inhalant take its place?

No comments: